BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22694851)

  • 1. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
    Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
    J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
    Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
    Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construct validity of the definition of primary graft dysfunction after lung transplantation.
    Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
    J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
    Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
    Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
    Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
    Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
    Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
    Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
    Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Ware LB; Wang F; Feng R; Christie JD;
    Am J Transplant; 2016 Mar; 16(3):833-40. PubMed ID: 26663441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.
    Christie JD; Robinson N; Ware LB; Plotnick M; De Andrade J; Lama V; Milstone A; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM
    Am J Respir Crit Care Med; 2007 Jan; 175(1):69-74. PubMed ID: 17023732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Graft Dysfunction and Mortality Following Lung Transplantation: A Role for Proadrenomedullin Plasma Levels.
    Riera J; Senna A; Cubero M; Roman A; Rello J;
    Am J Transplant; 2016 Feb; 16(2):634-9. PubMed ID: 26461449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
    Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
    Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.
    Cantu E; Diamond JM; Suzuki Y; Lasky J; Schaufler C; Lim B; Shah R; Porteous M; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Bermudez C; Crespo M; McDyer J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Hage C; Ware LB; Bellamy SL; Christie JD;
    Am J Respir Crit Care Med; 2018 Jan; 197(2):235-243. PubMed ID: 28872353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
    Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilation parameters and early graft function in double lung transplantation.
    Schwarz S; Benazzo A; Dunkler D; Muckenhuber M; Sorbo LD; Di Nardo M; Sinn K; Moser B; Matilla JR; Lang G; Taghavi S; Vamos FR; Jaksch P; Cypel M; Keshavjee S; Klepetko W; Hoetzenecker K
    J Heart Lung Transplant; 2021 Jan; 40(1):4-11. PubMed ID: 33144029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.
    Hashimoto K; Besla R; Zamel R; Juvet S; Kim H; Azad S; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Respir Crit Care Med; 2016 Jul; 194(1):97-105. PubMed ID: 26796350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.
    Diamond JM; Cantu E; Porteous MK; Suzuki Y; Meyer KC; Lederer DJ; Milewski RK; Arcasoy S; D'Ovidio F; Bacchetta M; Sonett JR; Singh G; Costa J; Tobias JW; Rodriguez H; Van Deerlin VM; Olthoff KM; Shaked A; Chang BL; Christie JD;
    Am J Transplant; 2017 Jul; 17(7):1770-1777. PubMed ID: 28117940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
    J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
    Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
    Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.